Corbus Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nasdaq climbing. 33. We always hear about beats but what do they really mean . Whats a great one . What really impacts the stock . What moves it. Take out a pen and paper and lets do some learning. The best kind of beat, the quarter we got today from Burlington Stores. Here is a discount clothing chain that has a track record of blowing the numbers and raising its forecast with the analysts aggressively following along. These kind of situations can be dangerous. After a while, the analysts want to get ahead of the up side surprises to make sure the company isnt manufacturing the goodness, the ...

StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report sent to investors on Saturday. A number of other research firms also recently issued reports on CRBP. Jefferies Financial Group raised shares of Corbus Pharmaceuticals from a hold rating to a buy rating […]

StockNews.com lowered shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. A number of other brokerages have also recently issued reports on CRBP. Royal Bank of Canada assumed coverage on Corbus Pharmaceuticals in a research report on Monday, May 13th. […]

StockNews.com downgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Other research analysts have also recently issued reports about the company. Oppenheimer boosted their price target on Corbus Pharmaceuticals from $58.00 to $60.00 and gave the stock an outperform rating […]

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $50.30 and last traded at $50.00, with a volume of 58166 shares trading hands. The stock had previously closed at $48.55. Analyst Upgrades and Downgrades Several equities analysts recently weighed […]